Product Datasheet
Cyclin D3 Antibody
Catalog Number: 49150
Technical:tech@swbio.com
Information:info@swbio.com
Description
- Swiss-Prot No.:
- Swiss-Prot#:P30281
- Form of Antibody:
- 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
- Immunogen:
- recombinant protein
- appl_detail:
- WB: 1:1,000
ICC: 1:50-1:200
FC: 1:10-1:50
- other_names:
- CCND 3 antibody Ccnd3 antibody CCND3_HUMAN antibody CyclinD3 antibody D3 type cyclin antibody G1 S specific cyclin D3 antibody G1/S specific cyclin D3 antibody G1/S-specific cyclin-D3 antibody
- Purification:
- ProA affinity purified
- Applications:
- WB, ICC/IF, FC
- Background:
- The proliferation of eukaryotic cells is controlled at specific points in the cell cycle, particularly at the G1 to S and the G2 to M transitions. It is well established that the Cdc2 p34-cyclin B protein kinase plays a critical role in the G2 to M transition while cyclin A associates with Cdk2 p33 and functions in S phase. Considerable effort directed towards the identification of G1 cyclins has led to the isolation of cyclin D, cyclin C and cyclin. Of these, cyclin D corresponds to a putative human oncogene, designated PRAD1, which maps at the site of the Bcl-1 rearrangement in certain lymphomas and leukemias. Two additional human type D cyclins, as well as their mouse homologs, have been identified. Evidence has established that members of the cyclin D family function to regulate phosphorylation of the retinoblastoma gene product, thereby activating E2F transcription factors.
© Signalway Biotechnology All Rights Reserved.